This report is a comprehensive study of the global market for epigenetic therapeutics. It describes the Epigenetic Therapeutics Market, which is segmented by product type and region.
As of July 2014, the market cap for Pain Therapeutics (PTIE) is $221,187,227.90.
As of July 2014, the market cap for Nektar Therapeutics (NKTR) is $1,398,016,781.01.
As of July 2014, the market cap for Celsus Therapeutics Plc (CLTX) is $22,728,791.75.
As of July 2014, the market cap for Cesca Therapeutics Inc. (KOOL) is $46,374,337.28.
As of July 2014, the market cap for Cymabay Therapeutics Inc. (CBAY) is $60,087,011.22.
As of July 2014, the market cap for Cytori Therapeutics Inc (CYTX) is $162,990,470.16.
As of July 2014, the market cap for Corcept Therapeutics Incorporated (CORT) is $246,180,984.24.
As of July 2014, the market cap for Regulus Therapeutics Inc. (RGLS) is $292,658,548.50.
As of July 2014, the market cap for Repros Therapeutics Inc. (RPRX) is $338,146,111.68.
As of July 2014, the market cap for Anika Therapeutics Inc. (ANIK) is $692,805,016.80.
As of July 2014, the market cap for United Therapeutics Corporation (UTHR) is $4,429,004,268.71.
As of July 2014, the market cap for Galectin Therapeutics Inc. (GALT) is $300,581,395.80.